Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 2
1(25.0%)
4Total
N/A(3)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07550140Not ApplicableRecruiting

ETASCAN Project: ETAS Project 2

Role: collaborator

NCT05763199Phase 2Active Not Recruiting

Standardized Extract of Cultured Lentinula Edodes Mycelia (AHCC®) in Ovarian Cancer Patients on Adjuvant Chemotherapy

Role: collaborator

NCT06790849Not ApplicableCompleted

ETASCAI Pilot Project

Role: collaborator

NCT01931930Not ApplicableCompleted

Effect of Perilla Extract on Improvement on Gastrointestinal Discomfort

Role: lead

All 4 trials loaded